Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition

Author

I. Rabbone

View on Semantic Scholar

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Salivary hormones and adipokines are associated with glycemic control and early renal and cardiometabolic markers in children and young adults with type 1 diabetes.

PURPOSE Type 1 diabetes (T1D) is recognized as a complex metabolic condition associated with hormonal dysregulation and early complications. This study aimed to evaluate salivary metabolic hormones and adipokines in children and young adults with T1D, and to assess their association with early markers of metabolic and...

A. Robino, G. Tornese, Luana Aldegheri et al. · 1 citation
Open access Aug 2026

Acute viral bronchiolitis before and after implementation of nirsevimab prophylaxis in Italy: a multicentre retrospective cohort study

Summary Background Acute viral bronchiolitis is the leading cause of hospitalisation in the first year of life, with Respiratory Syncytial Virus (RSV) accounting for more than 60% of cases. A long-acting monoclonal antibody (nirsevimab) has been introduced for infants entering their first epidemic season. 2024–2025 sea...

M. Spatuzzo, Antonio Corsello, M. Riccò et al. · 1 citation · ⚡1
Review Open access Sep 2026

Diagnostic Approach to Genetic Obesity in Children: From Pathophysiology to Precision Medicine—A Narrative Review

A narrative review summarizes the current knowledge on the genetic architecture of pediatric obesity, explores the transition from gene discovery to precision medicine, discusses available diagnostic algorithms and genetic testing strategies, and proposes an updated diagnostic flowchart.

Cristina Partenope, I. Rabbone, R. Pajno · 0 citations
Aug 2026

Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines.

CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.

M. Marigliano, A. Scaramuzza, C. Arnaldi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.